Clinical trial
L-Arginine Supplements in Treating Women Who Are Cancer Survivors
NCT00459134 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00459134 |
|---|---|
| Title | L-Arginine Supplements in Treating Women Who Are Cancer Survivors |
| Official title | A Randomized Study to Determine Whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement |
| Interventions | ArginMax, Placebo |
| Enrollment | 186 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Apr 11, 2007 |
| Last update posted | Sep 28, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: